ImmunoScore Signature
Lists
Only you see this
Abstract
The ISGC classifier could effectively predict recurrence and survival of GC, and complemented the prognostic value of the TNM staging system. Moreover, the ISGC might be a useful predictive tool to identify stage II and III GC patients who would benefit from adjuvant chemotherapy.
BibTeX
@article{jiang2016immunoscore,
author = {Yuming Jiang and Qi Zhang and Yanfeng Hu and Tuanjie Li and Jiang Yu and Liying Zhao and Gengtai Ye and Haijun Deng and Tingyu Mou and Shirong Cai and Zhiwei Zhou and Hao Liu and Guihua Chen and Guoxin Li and Xiaolong Qi},
title = {{ImmunoScore Signature}},
journal = {Annals},
year = {2016},
doi = {10.1097/sla.0000000000002116},
}Loading related content...